Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 8,11,14 Eicosatrienoic Acid
2. 8,11,14-eicosatrienoic Acid
3. Dihomo Gamma Linolenic Acid
4. Dihomogammalinolenic Acid
5. Homo Gamma Linolenic Acid
6. Homo-gamma Linolenic Acid
7. Linolenic Acid, Homo-gamma
8. Ro 12 1989
9. Ro 12-1989
10. Ro 121989
1. 1783-84-2
2. Dgla
3. 8,11,14-eicosatrienoic Acid
4. Gamma-homolinolenic Acid
5. Homo-gamma-linolenic Acid
6. Cis-8,11,14-eicosatrienoic Acid
7. Diroleuton
8. (8z,11z,14z)-icosa-8,11,14-trienoic Acid
9. All-cis-8,11,14-eicosatrienoic Acid
10. Bishomo-gamma-linolenic Acid
11. 8z,11z,14z-eicosatrienoic Acid
12. (z,z,z)-8,11,14-eicosatrienoic Acid
13. Ro 12-1989
14. (8z,11z,14z)-icosatrienoic Acid
15. 8,11,14-icosatrienoate
16. 8,11,14-eicosatrienoate
17. (z,z,z)-8,11,14-icosatrienoate
18. Daleuton
19. (z,z,z)-8,11,14-icosatrienoic Acid
20. Cis,cis,cis-8,11,14-eicosatrienoic Acid
21. .gamma.-homolinolenic Acid
22. (z,z,z)-8,11,14-eicosatrienoate
23. 8,11,14-all-cis-eicosatrienoic Acid
24. Dihomo-.gamma.-linolenic Acid
25. All Cis-8,11,14-eicosatrienoic Acid
26. All-cis-icosa-8,11,14-trienoic Acid
27. Ccris 7669
28. 8,11,14-eicosatrienoic Acid, (8z,11z,14z)-
29. (z,z,z)-icosatri-8,11,14-enoic Acid
30. Cis-8,cis-11,cis-14-eicosatrienoic Acid
31. Dihomo-gamma-linolenate
32. 8c,11c,14c-eicosatrienoic Acid
33. 8, 11, 14-eicosatrienoic Acid
34. Ds107
35. Eicosa-8z,11z,14z-trienoic Acid
36. Dihomo-
37. A-linolenic Acid
38. 20:3, N-6,9,12 All-cis
39. All-cis-8,11,14-icosatrienoic Acid
40. Bishomo-.gamma.-linolenic Acid
41. Chembl465183
42. Ds107g
43. Fc398rk06s
44. 8,11-14-eicosatrienoic Acid, (z,z,z)-
45. Chebi:53486
46. Ds-107
47. Ds-107g
48. 20:3 (.omega.-6) Fatty Acid
49. C20:3, N-6,9,12 All-cis
50. All-cis-eicosa-8,11,14-trienoic Acid
51. C20:3n-6,9,12
52. Fa(20:3(8z,11z,14z))
53. 20:3(n-6)
54. All-cis-8,11,14-eicosatrienoate
55. Homo-gamma-linolensaeure
56. 8,11,14-icosatrienoic Acid
57. Unii-fc398rk06s
58. Eicosatrienoate
59. Dihomolinolenate
60. Bml3-b11
61. 8c,11c,14c-eicosatriensaeure
62. Gamma-homolinolenate
63. Einecs 217-233-0
64. Mfcd00065721
65. All-cis-eicosa-8,11,14-triensaeure
66. Homo-gamma-linolenate
67. C 20:3 N-6
68. Bishomo-gamma-linolenate
69. Dihomo-y-linolenic Acid
70. Daleuton [inn]
71. Dihomo-gamma-linolenic-acid
72. Dibromo-gamma-linolenic Acid
73. Di-homo Gamma-linolenic Acid
74. Dihomo -gamma-linolenic Acid
75. Diroleuton [who-dd]
76. Bspbio_001286
77. Schembl842729
78. 8z,11z,14z-eicosatrienoate
79. Cis-8,11,14-eicosatrienoate
80. Gtpl9775
81. Dtxsid00912351
82. Hms1361a08
83. Hms1791a08
84. Hms1989a08
85. Hms3402a08
86. Hms3649h11
87. 8,11,14-all-cis-eicosatrienoate
88. Hy-a0143
89. Zinc4521470
90. Bdbm50269534
91. Lmfa01030158
92. All Cis-8,11,14-icosatrienoic Acid
93. (z,z,z)-icosatri-8,11,14-enoate
94. Cis,cis,cis-8,11,14-eicosatrienoate
95. Cis-8,cis-11,cis-14-eicosatrienoate
96. Db00154
97. Idi1_033756
98. Ncgc00161350-01
99. Ncgc00161350-02
100. Ncgc00161350-03
101. As-65384
102. 20:3n-6
103. Cis-8,11,14-eicosatrienoic Acid, >=99%
104. Cs-0017463
105. E0640
106. C03242
107. Dihomo- Gamma -linolenic Acid (20:3, N-6)
108. (8z,11z,14z)-8,11,14-eicosatrienoic Acid
109. Q415398
110. Sr-01000946659
111. 8,11,14-eicosatrienoic Acid, (z,z,z)- (8ci)
112. Sr-01000946659-1
113. Brd-k20152659-001-02-0
114. Cis-8,11,14-eicosatrienoic Acid, Analytical Standard
115. 8,11,14-eicosatrienoic Acid, (8z,11z,14z)- (9ci)
Molecular Weight | 306.5 g/mol |
---|---|
Molecular Formula | C20H34O2 |
XLogP3 | 7.2 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 15 |
Exact Mass | 306.255880323 g/mol |
Monoisotopic Mass | 306.255880323 g/mol |
Topological Polar Surface Area | 37.3 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 327 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 3 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
For nutritional supplementation, also for treating dietary shortage or imbalance
Treatment of atopic dermatitis
Dihomo gamma-linolenic acid or DHLA is an n-6 (omega-6) polyunsaturated fatty acid. It is comprised of 20 carbon atoms and three double bonds. DHLA is a byproduct of the 18 carbon gamma-linolenic acid (GLA). DHLA is then converted into prostaglandin E1 (PGE1). PGE1 inhibits platelet aggregation and also exerts a vasodilatory effect.
DHLA (or DGLA) is a precursor in the synthesis of prostaglandin E1 (PGE1) as well as the series-3 prostaglandins. It also serves as a precursor in the synthesis of eicosapentaenoic acid (EPA). EPA is a precursor of the series-3 prostaglandins, the series-5 leukotrienes and the series-3 thromboxanes. These eicosanoids have anti-thrombogenic, anti-inflammatory and anti-atherogenic properties. PGE1 inhibits platelet aggregation and has a vasodilation action. DHLA has also been shown to reduce the production/activity of tumor necrosis factor alpha.
Market Place
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?